| Chronic Kidney Disease | Staging and risk stratification | Levin A, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105:684-701. | 38519239 |
| Chronic Kidney Disease | Albuminuria categories | Murton M, et al. Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic review. Advances in Therapy. 2021;38:180-200. | 33231861 |
| Chronic Kidney Disease | SGLT2 era | Heerspink HJL, et al. Dapagliflozin in patients with chronic kidney disease. New England Journal of Medicine. 2020;383:1436-1446. | 32970396 |
| Chronic Kidney Disease | Nonsteroidal MRAs | Bakris GL, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. New England Journal of Medicine. 2020;383:2219-2229. | 33264825 |
| Chronic Kidney Disease | CKD anemia | Collister D, Rigatto C, Tangri N. Anemia management in chronic kidney disease and dialysis: a narrative review. Current Opinion in Nephrology and Hypertension. 2017;26:214-218. | 28306566 |
| Chronic Kidney Disease | CKD-MBD | Elias RM, et al. CKD-MBD: from the pathogenesis to the identification and development of potential novel therapeutic targets. Current Osteoporosis Reports. 2018;16:693-702. | 30291515 |
| Chronic Kidney Disease | Metabolic acidosis | Raphael KL. Metabolic acidosis in CKD: pathogenesis, adverse effects, and treatment effects. International Journal of Molecular Sciences. 2024;25:5187. | 38791238 |
| Chronic Kidney Disease | Cardiorenal overlap | Rangaswami J, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies. Circulation. 2019;139:e840-e878. | 30852913 |
| Acute Kidney Injury | KDIGO staging | Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary. Critical Care. 2013;17:204. | 23394211 |
| Acute Kidney Injury | Sepsis-AKI | Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H. Sepsis-associated acute kidney injury. Critical Care Clinics. 2021;37:279-301. | 33752856 |
| Acute Kidney Injury | Contrast nephropathy | Chalikias G, Drosos I, Tziakas DN. Contrast-induced acute kidney injury: an update. Cardiovascular Drugs and Therapy. 2016;30:215-228. | 26780748 |
| Acute Kidney Injury | Timing of dialysis | STARRT-AKI Investigators, et al. Timing of initiation of renal-replacement therapy in acute kidney injury. New England Journal of Medicine. 2020;383:240-251. | 32668114 |
| Acute Kidney Injury | AKI-to-CKD transition | Zhang T, Widdop RE, Ricardo SD. Transition from acute kidney injury to chronic kidney disease: mechanisms, models, and biomarkers. American Journal of Physiology-Renal Physiology. 2024;327:F788-F805. | 39298548 |
| Glomerular Disease | IgA nephropathy | Stoneman S, Teh JW, O'Shaughnessy MM. IgA nephropathy in adults: a review. JAMA. 2026. | 41587026 |
| Glomerular Disease | Membranous nephropathy | Ronco P, et al. Membranous nephropathy. Nature Reviews Disease Primers. 2021;7:69. | 34593809 |
| Glomerular Disease | Lupus nephritis | Houssiau FA, Lauwerys BR. Current management of lupus nephritis. Best Practice & Research Clinical Rheumatology. 2013;27:319-328. | 24238689 |
| Glomerular Disease | ANCA vasculitis | Konda R, Rajasekaran A, Rizk DV. Antineutrophil cytoplasmic antibody-associated vasculitis. Current Opinion in Nephrology and Hypertension. 2024;33:503-511. | 38785128 |
| Glomerular Disease | Complement disorders | Dixit S, et al. C3 glomerulopathy: advancements in diagnostics and therapeutics. Current Opinion in Nephrology and Hypertension. 2026. | 41208293 |
| Glomerular Disease | Podocytopathies | Hengel FE, et al. Autoantibodies targeting nephrin in podocytopathies. New England Journal of Medicine. 2024;390:2221-2232. | 38804512 |
| Electrolytes & Acid-Base | Sodium disorders | Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. Journal of the American Society of Nephrology. 2017;28:1340-1349. | 28174217 |
| Electrolytes & Acid-Base | Potassium disorders | Elliott TL, Braun M. Electrolytes: potassium disorders. FP Essentials. 2017;459:21-28. | 28806047 |
| Electrolytes & Acid-Base | Type 4 RTA | Palmer BF, Kelepouris E, Clegg DJ. Renal tubular acidosis and management strategies: a narrative review. Advances in Therapy. 2021;38:949-968. | 33367987 |
| Electrolytes & Acid-Base | Delta-delta reasoning | Rastegar A. Use of the delta anion gap/delta bicarbonate ratio in the diagnosis of mixed acid-base disorders. Journal of the American Society of Nephrology. 2007;18:2429-2431. | 17656477 |
| Electrolytes & Acid-Base | Toxic alcohols | Ross JA, Borek HA, Holstege CP. Toxic alcohols. Critical Care Clinics. 2021;37:643-656. | 34053711 |
| Dialysis & RRT | Adequacy | Torreggiani M, et al. Toward an individualized determination of dialysis adequacy: a narrative review with special emphasis on incremental hemodialysis. Expert Review of Molecular Diagnostics. 2021;21:1119-1137. | 34595991 |
| Dialysis & RRT | Ultrafiltration injury | Mermelstein A, et al. Ultrafiltration rate levels in hemodialysis patients associated with weight-specific mortality risks. Clinical Journal of the American Society of Nephrology. 2023;18:767-776. | 36913263 |
| Dialysis & RRT | CRRT dosing | Prowle JR, Schneider A, Bellomo R. Clinical review: optimal dose of continuous renal replacement therapy in acute kidney injury. Critical Care. 2011;15:207. | 21489322 |
| Dialysis & RRT | Incremental dialysis | Garofalo C, et al. Incremental dialysis in ESRD: systematic review and meta-analysis. Journal of Nephrology. 2019;32:823-836. | 30604150 |
| Dialysis & RRT | Peritoneal physiology | Khanna R, Nolph KD. The physiology of peritoneal dialysis. American Journal of Nephrology. 1989;9:504-512. | 2688427 |
| Transplant | Banff criteria | Loupy A, Mengel M, Haas M. Thirty years of the International Banff Classification for allograft pathology. Kidney International. 2022;101:678-691. | 34922989 |
| Transplant | AMR | Puttarajappa C, Shapiro R, Tan HP. Antibody-mediated rejection in kidney transplantation: a review. Journal of Transplantation. 2012;2012:193724. | 22577514 |
| Transplant | Cellular rejection | Halloran PF. T cell-mediated rejection of kidney transplants: a personal viewpoint. American Journal of Transplantation. 2010;10:1126-1134. | 20346061 |
| Transplant | BK nephropathy | Borriello M, et al. BK virus infection and BK-virus-associated nephropathy in renal transplant recipients. Genes. 2022;13:1290. | 35886073 |
| Transplant | Immunosuppressant toxicities | Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clinical Journal of the American Society of Nephrology. 2009;4:481-508. | 19218475 |
| Hereditary Kidney Disease | ADPKD | Chebib FT, Hanna C, Harris PC, Torres VE, Dahl NK. Autosomal dominant polycystic kidney disease: a review. JAMA. 2025. | 40126492 |
| Hereditary Kidney Disease | Alport | Savige J. Alport syndrome: an update. Current Opinion in Nephrology and Hypertension. 2025;34:206-211. | 39840589 |
| Hereditary Kidney Disease | APOL1 | Friedman DJ, Pollak MR. APOL1 nephropathy: from genetics to clinical applications. Clinical Journal of the American Society of Nephrology. 2021;16:294-303. | 32616495 |
| Hereditary Kidney Disease | Fabry disease | Del Pino M, et al. Fabry nephropathy: an evidence-based narrative review. Kidney and Blood Pressure Research. 2018;43:406-421. | 29558749 |